US Stock MarketDetailed Quotes

A Agilent Technologies

Watchlist
  • 142.920
  • +0.390+0.27%
Close Aug 30 16:00 ET
  • 142.920
  • 0.0000.00%
Post 16:35 ET
41.06BMarket Cap29.71P/E (TTM)

Agilent Technologies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jul 31, 2024
(Q2)Apr 30, 2024
(Q1)Jan 31, 2024
(FY)Oct 31, 2023
(Q4)Oct 31, 2023
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-19.57%452M
-16.33%333M
63.85%485M
35.06%1.77B
15.18%516M
72.39%562M
40.64%398M
16.08%296M
-11.65%1.31B
1.59%448M
Net income from continuing operations
154.05%282M
1.99%308M
-1.14%348M
-1.12%1.24B
29.08%475M
-66.26%111M
10.22%302M
24.38%352M
3.64%1.25B
-16.74%368M
Operating gains losses
-100.00%-2M
-125.00%-1M
-130.00%-3M
-102.63%-2M
-314.29%-15M
-114.29%-1M
-73.33%4M
-78.72%10M
193.83%76M
109.46%7M
Depreciation and amortization
-11.27%63M
-11.27%63M
-7.46%62M
-14.51%271M
-15.07%62M
-11.25%71M
-13.41%71M
-18.29%67M
-1.25%317M
-13.10%73M
Deferred tax
98.53%-1M
-40.00%-7M
--0
-800.00%-56M
176.47%13M
-1,233.33%-68M
0.00%-5M
-83.33%4M
-42.86%8M
37.04%-17M
Other non cash items
14.29%16M
55.56%14M
-44.44%5M
370.00%47M
66.67%15M
100.00%14M
164.29%9M
12.50%9M
-9.09%10M
181.82%9M
Change In working capital
-48.84%66M
-971.43%-75M
111.05%21M
75.73%-116M
-166.67%-48M
198.47%129M
92.71%-7M
18.45%-190M
-368.63%-478M
-460.00%-18M
-Change in receivables
-64.06%23M
-37.04%34M
300.00%10M
141.12%132M
121.59%19M
151.20%64M
187.10%54M
89.13%-5M
-150.78%-321M
-49.15%-88M
-Change in inventory
-33.33%12M
700.00%12M
86.96%-9M
86.69%-33M
147.62%20M
121.95%18M
97.14%-2M
-27.78%-69M
-82.35%-248M
-100.00%-42M
-Change in payables and accrued expense
187.50%14M
72.97%-20M
411.11%84M
-241.32%-171M
-590.91%-54M
-128.57%-16M
-535.29%-74M
-172.97%-27M
89.06%121M
-38.89%11M
-Change in other working capital
-73.02%17M
-773.33%-101M
28.09%-64M
-46.67%-44M
-132.67%-33M
215.00%63M
-21.05%15M
47.65%-89M
-130.61%-30M
50.75%101M
Cash from discontinued investing activities
Operating cash flow
-19.57%452M
-16.33%333M
63.85%485M
35.06%1.77B
15.18%516M
72.39%562M
40.64%398M
16.08%296M
-11.65%1.31B
1.59%448M
Investing cash flow
Cash flow from continuing investing activities
-12.36%-100M
-41.56%-109M
8.65%-95M
8.28%-310M
63.64%-40M
-21.92%-89M
-1.32%-77M
-31.65%-104M
54.87%-338M
-86.44%-110M
Net PPE purchase and sale
-13.58%-92M
-80.70%-103M
-18.42%-90M
-2.41%-298M
-20.00%-84M
1.22%-81M
10.94%-57M
-1.33%-76M
-55.61%-291M
-14.75%-70M
Net business purchase and sale
---3M
--0
--0
98.08%-1M
247.06%50M
--0
-16.67%-21M
---30M
90.49%-52M
---34M
Net investment purchase and sale
0.00%-2M
-400.00%-3M
--0
-133.33%-3M
-66.67%-5M
-122.22%-2M
-83.33%1M
200.00%3M
190.00%9M
-160.00%-3M
Net other investing changes
50.00%-3M
---3M
-400.00%-5M
-100.00%-8M
66.67%-1M
---6M
--0
0.00%-1M
20.00%-4M
0.00%-3M
Cash from discontinued investing activities
Investing cash flow
-12.36%-100M
-41.56%-109M
8.65%-95M
8.28%-310M
63.64%-40M
-21.92%-89M
-1.32%-77M
-31.65%-104M
54.87%-338M
-86.44%-110M
Financing cash flow
Cash flow from continuing financing activities
23.60%-246M
25.38%-291M
-1,311.76%-240M
32.22%-930M
41.06%-201M
11.05%-322M
-217.07%-390M
96.89%-17M
-97.13%-1.37B
-5.25%-341M
Net issuance payments of debt
581.82%375M
--0
-188.67%-180M
-234.62%-35M
62.07%-55M
1,475.00%55M
-236.00%-238M
--203M
-92.70%26M
-11.54%-145M
Net common stock issuance
-74.63%-585M
-170.59%-230M
--0
49.52%-575M
40.74%-80M
-3.72%-335M
63.68%-85M
83.22%-75M
-44.54%-1.14B
0.74%-135M
Cash dividends paid
-3.03%-68M
-4.55%-69M
-2.99%-69M
-6.00%-265M
-6.45%-66M
-6.45%-66M
-4.76%-66M
-6.35%-67M
-5.93%-250M
-5.08%-62M
Proceeds from stock option exercised by employees
10.00%33M
--9M
-2.86%34M
15.52%67M
-33.33%2M
7.14%30M
--0
29.63%35M
5.45%58M
0.00%3M
Net other financing activities
83.33%-1M
0.00%-1M
77.88%-25M
-82.09%-122M
0.00%-2M
-500.00%-6M
0.00%-1M
-79.37%-113M
19.28%-67M
0.00%-2M
Cash from discontinued financing activities
Financing cash flow
23.60%-246M
25.38%-291M
-1,311.76%-240M
32.22%-930M
41.06%-201M
11.05%-322M
-217.07%-390M
96.89%-17M
-97.13%-1.37B
-5.25%-341M
Net cash flow
Beginning cash position
42.11%1.67B
39.66%1.75B
50.85%1.59B
-29.13%1.06B
24.14%1.33B
-0.84%1.18B
12.28%1.25B
-29.13%1.06B
2.97%1.49B
-25.23%1.07B
Current changes in cash
-29.80%106M
2.90%-67M
-14.29%150M
233.67%532M
9,266.67%275M
238.53%151M
-182.14%-69M
147.30%175M
-1,095.00%-398M
-105.17%-3M
Effect of exchange rate changes
-33.33%2M
-50.00%-9M
-68.18%7M
113.89%5M
0.00%-14M
150.00%3M
50.00%-6M
650.00%22M
-1,300.00%-36M
-366.67%-14M
End cash Position
33.78%1.78B
42.11%1.67B
39.66%1.75B
50.85%1.59B
50.85%1.59B
24.14%1.33B
-0.84%1.18B
12.28%1.25B
-29.13%1.06B
-29.13%1.06B
Free cash flow
-25.16%360M
-32.55%230M
79.55%395M
44.37%1.47B
14.29%432M
97.13%481M
55.71%341M
22.22%220M
-21.28%1.02B
-0.26%378M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jul 31, 2024(Q2)Apr 30, 2024(Q1)Jan 31, 2024(FY)Oct 31, 2023(Q4)Oct 31, 2023(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -19.57%452M-16.33%333M63.85%485M35.06%1.77B15.18%516M72.39%562M40.64%398M16.08%296M-11.65%1.31B1.59%448M
Net income from continuing operations 154.05%282M1.99%308M-1.14%348M-1.12%1.24B29.08%475M-66.26%111M10.22%302M24.38%352M3.64%1.25B-16.74%368M
Operating gains losses -100.00%-2M-125.00%-1M-130.00%-3M-102.63%-2M-314.29%-15M-114.29%-1M-73.33%4M-78.72%10M193.83%76M109.46%7M
Depreciation and amortization -11.27%63M-11.27%63M-7.46%62M-14.51%271M-15.07%62M-11.25%71M-13.41%71M-18.29%67M-1.25%317M-13.10%73M
Deferred tax 98.53%-1M-40.00%-7M--0-800.00%-56M176.47%13M-1,233.33%-68M0.00%-5M-83.33%4M-42.86%8M37.04%-17M
Other non cash items 14.29%16M55.56%14M-44.44%5M370.00%47M66.67%15M100.00%14M164.29%9M12.50%9M-9.09%10M181.82%9M
Change In working capital -48.84%66M-971.43%-75M111.05%21M75.73%-116M-166.67%-48M198.47%129M92.71%-7M18.45%-190M-368.63%-478M-460.00%-18M
-Change in receivables -64.06%23M-37.04%34M300.00%10M141.12%132M121.59%19M151.20%64M187.10%54M89.13%-5M-150.78%-321M-49.15%-88M
-Change in inventory -33.33%12M700.00%12M86.96%-9M86.69%-33M147.62%20M121.95%18M97.14%-2M-27.78%-69M-82.35%-248M-100.00%-42M
-Change in payables and accrued expense 187.50%14M72.97%-20M411.11%84M-241.32%-171M-590.91%-54M-128.57%-16M-535.29%-74M-172.97%-27M89.06%121M-38.89%11M
-Change in other working capital -73.02%17M-773.33%-101M28.09%-64M-46.67%-44M-132.67%-33M215.00%63M-21.05%15M47.65%-89M-130.61%-30M50.75%101M
Cash from discontinued investing activities
Operating cash flow -19.57%452M-16.33%333M63.85%485M35.06%1.77B15.18%516M72.39%562M40.64%398M16.08%296M-11.65%1.31B1.59%448M
Investing cash flow
Cash flow from continuing investing activities -12.36%-100M-41.56%-109M8.65%-95M8.28%-310M63.64%-40M-21.92%-89M-1.32%-77M-31.65%-104M54.87%-338M-86.44%-110M
Net PPE purchase and sale -13.58%-92M-80.70%-103M-18.42%-90M-2.41%-298M-20.00%-84M1.22%-81M10.94%-57M-1.33%-76M-55.61%-291M-14.75%-70M
Net business purchase and sale ---3M--0--098.08%-1M247.06%50M--0-16.67%-21M---30M90.49%-52M---34M
Net investment purchase and sale 0.00%-2M-400.00%-3M--0-133.33%-3M-66.67%-5M-122.22%-2M-83.33%1M200.00%3M190.00%9M-160.00%-3M
Net other investing changes 50.00%-3M---3M-400.00%-5M-100.00%-8M66.67%-1M---6M--00.00%-1M20.00%-4M0.00%-3M
Cash from discontinued investing activities
Investing cash flow -12.36%-100M-41.56%-109M8.65%-95M8.28%-310M63.64%-40M-21.92%-89M-1.32%-77M-31.65%-104M54.87%-338M-86.44%-110M
Financing cash flow
Cash flow from continuing financing activities 23.60%-246M25.38%-291M-1,311.76%-240M32.22%-930M41.06%-201M11.05%-322M-217.07%-390M96.89%-17M-97.13%-1.37B-5.25%-341M
Net issuance payments of debt 581.82%375M--0-188.67%-180M-234.62%-35M62.07%-55M1,475.00%55M-236.00%-238M--203M-92.70%26M-11.54%-145M
Net common stock issuance -74.63%-585M-170.59%-230M--049.52%-575M40.74%-80M-3.72%-335M63.68%-85M83.22%-75M-44.54%-1.14B0.74%-135M
Cash dividends paid -3.03%-68M-4.55%-69M-2.99%-69M-6.00%-265M-6.45%-66M-6.45%-66M-4.76%-66M-6.35%-67M-5.93%-250M-5.08%-62M
Proceeds from stock option exercised by employees 10.00%33M--9M-2.86%34M15.52%67M-33.33%2M7.14%30M--029.63%35M5.45%58M0.00%3M
Net other financing activities 83.33%-1M0.00%-1M77.88%-25M-82.09%-122M0.00%-2M-500.00%-6M0.00%-1M-79.37%-113M19.28%-67M0.00%-2M
Cash from discontinued financing activities
Financing cash flow 23.60%-246M25.38%-291M-1,311.76%-240M32.22%-930M41.06%-201M11.05%-322M-217.07%-390M96.89%-17M-97.13%-1.37B-5.25%-341M
Net cash flow
Beginning cash position 42.11%1.67B39.66%1.75B50.85%1.59B-29.13%1.06B24.14%1.33B-0.84%1.18B12.28%1.25B-29.13%1.06B2.97%1.49B-25.23%1.07B
Current changes in cash -29.80%106M2.90%-67M-14.29%150M233.67%532M9,266.67%275M238.53%151M-182.14%-69M147.30%175M-1,095.00%-398M-105.17%-3M
Effect of exchange rate changes -33.33%2M-50.00%-9M-68.18%7M113.89%5M0.00%-14M150.00%3M50.00%-6M650.00%22M-1,300.00%-36M-366.67%-14M
End cash Position 33.78%1.78B42.11%1.67B39.66%1.75B50.85%1.59B50.85%1.59B24.14%1.33B-0.84%1.18B12.28%1.25B-29.13%1.06B-29.13%1.06B
Free cash flow -25.16%360M-32.55%230M79.55%395M44.37%1.47B14.29%432M97.13%481M55.71%341M22.22%220M-21.28%1.02B-0.26%378M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg
Concept Gene Editing
Gene Editing
Intraday+0.41%